Drugmaker Valeant to buy Bausch & Lomb for $8.7 billion | TORONTO/WINNIPEG, Manitoba (Reuters) - Valeant Pharmaceuticals International said on Monday it agreed to buy Bausch & Lomb Holdings Inc from Warburg Pincus LLC for $8.7 billion, a cash deal set to vault the Canadian company into the upper ranks of the global pharmaceutical sector. | | | | | | The new tech palaces: visionary HQs, or cursed trophies? | SEATTLE/SAN FRANCISCO (Reuters) - While much of corporate America is retrenching on the real estate front, the four most influential technology companies in America are each planning headquarters that could win a Pritzker Architecture Prize for hubris. | | | | | | EU quizzes telcos on Apple sales tactics against rivals | BRUSSELS (Reuters) - EU antitrust regulators are seeking information whether Apple's iPhone distribution deals with mobile telecoms operators may be aimed at shutting out rival smartphones makers, in a move which could lead to a formal investigation into Apple. | | | | | | Pressure growing for ownership change at ILVA steel plant | ROME (Reuters) - Italy's government on Monday met with the board of ILVA, the steel group mired in a growing environmental and corruption scandal, as pressure mounted for a change in the ownership structure of Europe's largest steel plant. | | | | | | EU duties on Chinese solar panels losing member state support | BRUSSELS (Reuters) - A majority of EU governments oppose a plan to impose hefty duties on solar panel imports from China, a survey of member states showed on Monday, undermining efforts by Brussels to pressure Beijing over its trade practices. | | | | | | | A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today | | | | | | | The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today | | | | | » MORE NEWSLETTERS | |
No comments:
Post a Comment